As we look over the evolution of medicine, we see we have gone from what can be described as crude experimentation in ancient times to more sophisticated ways of managing the signs and symptoms of a disease in the past century. The effort to dig deeper through the layers of a disease to reach its…
The challenge for scientists is to develop immunotherapies targeting new molecular sites that can provide consistent clinical benefits in GIST patients.
The clinical management of metastatic gastrointestinal stromal tumor (GIST) has greatly improved since the early 2000s.
A review of current clinical practices provides a valuable snapshot of where we are today in terms of the molecular diagnosis of cancers such as GISTs.
Much scientific research in recent years has centered on uncovering prognostic indicators for malignant diseases. The main goal of treatment is always curative, but in cases in which that is currently impossible, the physician’s attention then turns toward extending and improving the quality of life of patients. Gastrointestinal stromal tumors (GIST) are cancers that can…
Please login or register first to view this content.
